Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEOGB: Neoadjuvant Chemotherapy vs Upfront Surgery in Gallbladder Cancer
NCT06712420Phase 3Recruiting
- Sponsor
- Rajiv Gandhi Cancer Institute and Research Centre
- Start
- Jan 2025
- Primary completion
- Apr 2028
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine, Cisplatin micelle injection (HA132) in gallbladder cancer, sponsored by Rajiv Gandhi Cancer Institute and Research Centre. Started Jan 2025; status: recruiting.
02
Drugs
gemcitabineCisplatin micelle injection (HA132)
03
Conditions
gallbladder cancer
Beyond the preview
Go deeper on NCT06712420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06712420.